Baird Financial Group
AVEO

Baird Financial Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Baird Financial Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-57,283
Closed -$320K – 1896
2022
Q1 		$320K Buy
57,283
+5,154
+10% +$21.2K ﹤0.01% 1593
2021
Q4 		$244K Sell
52,129
-5,001
-9% -$31K ﹤0.01% 1757
2021
Q3 		$353K Sell
57,130
-2,055
-3% -$12.3K ﹤0.01% 1607
2021
Q2 		$390K Buy
59,185
+5,753
+11% +$39.7K ﹤0.01% 1492
2021
Q1 		$391K Buy
+53,432
New +$461K ﹤0.01% 1428
2019
Q4 		– Sell
-9,863
Closed -$83K – 1578
2019
Q3 		$83K Buy
+9,863
New +$73.4K ﹤0.01% 1485

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Baird Financial Group's AVEO Position: Q2 2022 in Review

Baird Financial Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2022, closing a stake of 57,283 shares — an estimated $320K sold.

Baird Financial Group first reported a position in AVEO in Q3 2019 and held it in 6 quarters. The position peaked at $391K in Q1 2021. 56 funds tracked by Wall St. Rank hold AVEO as of Q2 2022.

  • Baird Financial Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Baird Financial Group sold 57,283 AVEO Pharmaceuticals, Inc. shares in Q2 2022, an estimated $320K.
  • Baird Financial Group first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2019 and held it in 6 quarters.
  • Baird Financial Group's AVEO Pharmaceuticals, Inc. position peaked at $391K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2022.

Based on Baird Financial Group's 13F filing for Q2 2022, filed 8 Aug 2022.